Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL42

CLOZAPINE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1

Basic Information

ChEMBL ID CHEMBL42
Name CLOZAPINE
Phase Approved
Structure Type MOL
InChI Key QZUDBNBUXVUHMW-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Clozapina Clozapine Clozapine (caraco) Clozapine (clozaril) Clozapine (fazaclo) Clozapine (ivax) Clozapine (mylan) Clozapine (teva) Clozapine (udl) Clozapine (versacloz) Clozapine resolution mixture Clozaril +8 more
103
Targets
861
Activities
4
Assay Types
30
PK Parameters
20
Publications
20
Known Names
9
Indications
2
Mechanisms

Molecular Properties

326.8
MW (Da)
3.72
ALogP
4
HBA
1
HBD
30.9
PSA (Ų)
0.80
QED
0
Ro5 Violations
0
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1989
Availability Prescription
Chirality Achiral

Routes of Administration

Oral

Flags

Black Box Warning Natural Product
USAN Stem -pine
USAN Year 1969

Extended Properties

Molecular Formula C18H19ClN4
MW 326.83
Aromatic Rings 2
Heavy Atoms 23
NP-Likeness -0.78

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Serotonin 2a (5-HT2a) receptor antagonist ANTAGONIST 5-hydroxytryptamine receptor 2A
Dopamine D2 receptor antagonist ANTAGONIST D(2) dopamine receptor

Indications

Psychotic Disorders Psychotic Disorders Schizophrenia Anxiety Bipolar Disorder Dementia Depressive Disorder Developmental Disabilities Intellectual Disability

ATC Classification

N05AH02
clozapine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS

Drug Warnings

Black Box Warning
hematological toxicity
Country: United States
Black Box Warning
cardiotoxicity
Country: United States
Black Box Warning
vascular toxicity
Country: United States
Black Box Warning
neurotoxicity
Country: United States
Black Box Warning
infectious disease
Country: United States

Activity Summary

Ki 634 meas. best 9.24
IC50 204 meas. best 8.52
Kd 16 meas. best 9.16
EC50 7 meas. best 9.4

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Histamine H1 receptor
CHEMBL231
EC50 9.4 9.4 0.4 1
Histamine H1 receptor
CHEMBL231
Ki 9.24 8.675 0.6 10
5-hydroxytryptamine receptor 2A
CHEMBL322
Kd 9.16 8.89 0.7 2
Unchecked
CHEMBL612545
Kd 9.16 9.16 0.7 1
Muscarinic acetylcholine receptor M1
CHEMBL216
Ki 9.01 8.3833 1.0 6
Alpha-2C adrenergic receptor
CHEMBL1916
Ki 8.94 8.16 1.1 3
5-hydroxytryptamine receptor 2A
CHEMBL224
Ki 8.92 8.0605 1.2 41
Adrenergic receptor alpha-1
CHEMBL1907610
Ki 8.85 8.0133 1.4 18
Unchecked
CHEMBL612545
Ki 8.85 7.31 1.4 15
5-hydroxytryptamine receptor 2A
CHEMBL322
Ki 8.8 8.0062 1.6 29
Serotonin 2 (5-HT2) receptor
CHEMBL2093870
Ki 8.74 8.15 1.8 10
Muscarinic acetylcholine receptor M1
CHEMBL276
Ki 8.68 7.7367 2.1 3
5-hydroxytryptamine receptor 2C
CHEMBL225
Ki 8.54 7.91 2.9 26
Histamine H1 receptor
CHEMBL4701
Ki 8.54 8.23 2.9 3
5-hydroxytryptamine receptor 2A
CHEMBL3446
IC50 8.52 8.52 3.0 1
Histamine H1 receptor
CHEMBL231
Kd 8.51 8.51 3.1 1
5-hydroxytryptamine receptor 2B
CHEMBL1833
Ki 8.5 8.26 3.2 3
Alpha-1B adrenergic receptor
CHEMBL315
Ki 8.45 7.8775 3.6 4
Adrenergic receptor alpha-1
CHEMBL2094251
Ki 8.43 7.8375 3.7 4
Histamine H1 receptor
CHEMBL3943
Ki 8.42 8.138 3.8 5
Adrenergic receptor alpha-1
CHEMBL1907610
IC50 8.4 7.5717 4.0 12
Alpha adrenergic receptor 1A and 1B
CHEMBL2111476
Ki 8.4 8.4 4.0 1
5-hydroxytryptamine receptor 6
CHEMBL3371
Ki 8.4 8.1044 4.0 16
5-hydroxytryptamine receptor 2A
CHEMBL224
IC50 8.38 8.15 4.2 2
Histamine H1 receptor
CHEMBL231
IC50 8.31 8.31 4.9 1
Serotonin 2 (5-HT2) receptor
CHEMBL2095200
Ki 8.3 8.11 5.0 2
5-hydroxytryptamine receptor 7
CHEMBL3155
Ki 8.26 7.6026 5.5 31
5-hydroxytryptamine receptor 2C
CHEMBL225
IC50 8.22 8.11 6.0 2
Muscarinic acetylcholine receptor M4
CHEMBL1821
Ki 8.2 7.7 6.3 3
5-hydroxytryptamine receptor 1A
CHEMBL214
Ki 8.2 6.8747 6.4 15
5-hydroxytryptamine receptor 7
CHEMBL3223
Ki 8.2 7.7667 6.3 3
Alpha-1B adrenergic receptor
CHEMBL315
IC50 8.19 8.19 6.5 1
Homo sapiens
CHEMBL372
EC50 8.19 8.19 6.4 1
D(2) dopamine receptor
CHEMBL217
Ki 8.15 7.0024 7.1 80
D(1A) dopamine receptor
CHEMBL2056
Ki 8.12 7.044 7.5 15
Serotonin 2 (5-HT2) receptor
CHEMBL2093870
IC50 8.11 7.585 7.8 10
5-hydroxytryptamine receptor 2A
CHEMBL322
IC50 8.11 7.76 7.8 6
Alpha-2C adrenergic receptor
CHEMBL1916
IC50 8.1 8.1 7.9 1
5-hydroxytryptamine receptor 2C
CHEMBL324
Ki 8.1 7.7483 8.0 6
D(2) dopamine receptor
CHEMBL217
IC50 8.05 6.556 9.0 10
D(4) dopamine receptor
CHEMBL3361
Ki 8.05 7.6967 9.0 3
Histamine H1 receptor
CHEMBL4701
IC50 8.05 7.7767 9.0 3
Muscarinic acetylcholine receptor M1
CHEMBL216
IC50 8.03 8.02 9.4 3
Muscarinic acetylcholine receptor M5
CHEMBL2035
Ki 8.02 7.51 9.5 2
D(4) dopamine receptor
CHEMBL219
Ki 8.0 7.5778 10.0 55
Alpha-1A adrenergic receptor
CHEMBL229
Ki 8.0 7.8133 10.0 3
Alpha-1B adrenergic receptor
CHEMBL232
Ki 8.0 8.0 10.0 1
Hypothalamus
CHEMBL613575
EC50 8.0 8.0 10.0 1
5-hydroxytryptamine receptor 2B
CHEMBL1833
IC50 7.96 7.96 11.0 1
Alpha-2B adrenergic receptor
CHEMBL1942
Ki 7.96 7.48 11.0 2

Pharmacokinetic Data

Parameter Value Units Species
AUC 1761.94 ng.hr.mL-1 Rattus norvegicus
AUC 14.49 ng.hr.mL-1 Rattus norvegicus
CL 2.5 mL.min-1.kg-1 Homo sapiens
CL 2.5 mL.min-1.kg-1 Homo sapiens
CL 2.5 mL.min-1.kg-1 Homo sapiens
CL 2.5 mL.min-1.kg-1 Homo sapiens
CL 6.76 uL.min-1.(10^6cells)-1 Homo sapiens
CL 15.14 mL.min-1.g-1 Homo sapiens
CL 150.0 uL.min-1.(10^6cells)-1 Rattus norvegicus
CL 0.000147 mL.min-1.g-1 Homo sapiens
CL 1.2e-05 mL.min-1.g-1 Homo sapiens
CL 0.44 mL.min-1.g-1 Rattus norvegicus
CL 0.07 mL.min-1.g-1 Rattus norvegicus
CL 2006.0 mL.min-1.kg-1 Rattus norvegicus
CL 98.0 mL.min-1.kg-1 Homo sapiens
CL 0.1 mL.min-1.kg-1 Homo sapiens
CL 5.4 mL.min-1.kg-1 Homo sapiens
CL 0.159 uL/min Homo sapiens
CL 17.4 mL.min-1.g-1 Homo sapiens
CL 10.3 mL.min-1.kg-1 Homo sapiens
CL 82.4 mL.min-1.kg-1 Mus musculus
CL 6.8 mL.min-1.g-1 Mus musculus
CL 5.8 mL.min-1.g-1 Homo sapiens
CL 20.4 mL.min-1.g-1 Rattus norvegicus
CL 35.9 mL.min-1.g-1 Mus musculus
CL 55.1 mL.min-1.kg-1 Mus musculus
CL 142.0 mL.min-1.kg-1 Mus musculus
Cmax 6.0 nM Rattus norvegicus
Cmax 3490.0 nM Homo sapiens
F 79.0 % Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Histamine H1 receptor EC50 = 0.4 nM 9.4 Inverse agonist activity at human histamine H1 receptor by R-SAT assay -
Histamine H1 receptor Ki = 0.571 nM 9.24 DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) -
5-hydroxytryptamine receptor 2A Kd = 0.6918 nM 9.16 Negative log concentration of antagonist on 5-hydroxytryptamine 2A receptor in r... 11754579
Unchecked Kd = 0.6918 nM 9.16 pA2 value was evaluated by measuring the inhibition of the 5-HT-induced contract... 10425088
Muscarinic acetylcholine receptor M1 Ki = 0.98 nM 9.01 Binding affinity towards human M1 muscarinic receptor. 11170639
Histamine H1 receptor Ki = 1.0 nM 9.0 Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1... -
Histamine H1 receptor Ki = 1.0 nM 9.0 Inhibition of histamine H1 receptor (unknown origin) 24559051
Histamine H1 receptor Ki = 1.1 nM 8.96 Inhibition of [3H]pyrilamine binding to human Histamine H1 receptor 15771415
Alpha-2C adrenergic receptor Ki = 1.144 nM 8.94 DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) -
5-hydroxytryptamine receptor 2A Ki = 1.199 nM 8.92 DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: ... -
Adrenergic receptor alpha-1 Ki = 1.4 nM 8.85 Binding affinity against Alpha-1 adrenergic receptor from rat cerebral cortex 9622541
Adrenergic receptor alpha-1 Ki = 1.4 nM 8.85 Binding affinity towards alpha-1 adrenergic receptors in rat brain synaptosomal ... 7909336
Adrenergic receptor alpha-1 Ki = 1.4 nM 8.85 Evaluated for binding affinity against alpha-1 adrenergic receptor 10893315
Unchecked Ki = 1.4 nM 8.85 Binding affinity to adrenergic alpha1 receptor 18378462
5-hydroxytryptamine receptor 2A Ki = 1.4 nM 8.85 Binding affinity to human 5HT2A receptor 32976928
5-hydroxytryptamine receptor 2A Ki = 1.585 nM 8.8 Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed... 10821703
Histamine H1 receptor Ki = 1.8 nM 8.74 Displacement of [3H]pyrilamine from human H1 receptor by liquid scintillation co... 22245230
Serotonin 2 (5-HT2) receptor Ki = 1.8 nM 8.74 Binding affinity determined in radioreceptor binding assay by using [3H]ketanser... 1346653
Muscarinic acetylcholine receptor M1 Ki = 1.8 nM 8.74 Displacement of [3H]QNB from human M1 receptor by liquid scintillation counting 22245230
Muscarinic acetylcholine receptor M1 Ki = 1.8 nM 8.74 Binding affinity to human cloned muscarinic M1 receptor 18595716

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL3885881 Rattus norvegicus 199
- 10.5281/zenodo.13943903 ADMET 89
31158845 10.1038/s41586-019-1291-3 ADMET 62
- 10.6019/CHEMBL4295262 Unchecked 36
2571727 10.1021/jm00130a003 Mus musculus 27
23297297 10.1124/dmd.112.050484 Cytochrome P450 3A4 25
17360666 10.1073/pnas.0611417104 Mus musculus 22
23297297 10.1124/dmd.112.050484 Liver microsome 19
16472241 10.2174/1570163043334794 Hepatotoxicity 18
23297297 10.1124/dmd.112.050484 Cytochrome P450 2D6 16
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
11392544 10.1016/s0960-894x(01)00200-1 Mus musculus 14
2571727 10.1021/jm00130a003 Rattus norvegicus 11
18024584 10.1073/pnas.0709695104 H4 11
15646539 10.1016/s0399-8320(04)95062-2 Unchecked 11
2891853 10.1021/jm00396a016 Mus musculus 10
8831770 10.1021/jm960268u Rattus norvegicus 10
15771414 10.1021/jm049629t Rattus norvegicus 10
34721 10.1021/jm00190a009 Mus musculus 10
16854056 10.1021/jm051008s Histamine H4 receptor 9

Data from ChEMBL 36 via Core Engine